BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33298651)

  • 21. The economic research of arsenic trioxide for the treatment of newly diagnosed acute promyelocytic leukemia in China.
    Chen X; Hong Y; Zheng P; You X; Feng J; Huang Z; Wang Y
    Cancer; 2020 Jan; 126(2):311-321. PubMed ID: 31714584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Complete remission induced by combined treatment with all-trans retinoic acid (ATRA) and granulocyte colony-stimulating factor (G-CSF) in a patient with relapsed acute promyelocytic leukemia].
    Wakayama T; Furuya H; Takagi C; Ichiba S; Kato Y
    Rinsho Ketsueki; 1994 Nov; 35(11):1315-21. PubMed ID: 7529843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial.
    Zhang L; Zou Y; Chen Y; Guo Y; Yang W; Chen X; Wang S; Liu X; Ruan M; Zhang J; Liu T; Liu F; Qi B; An W; Ren Y; Chang L; Zhu X
    BMC Cancer; 2018 Apr; 18(1):374. PubMed ID: 29615003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of an acute promyelocytic leukemia relapse using arsenic trioxide and all-trans-retinoic in a 6-year-old child.
    Rock N; Mattiello V; Judas C; Huezo-Diaz P; Bourquin JP; Gumy-Pause F; Ansari M
    Pediatr Hematol Oncol; 2014 Mar; 31(2):143-8. PubMed ID: 24498972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute promyelocytic leukemia relapse as leukemia cutis shortly after complete remission with all-trans retinoic acid].
    Itoh K; Gotoh W; Yagasaki F; Itoh Y; Kawai N; Matsuda A; Tominaga K; Kusumoto S; Ino H; Murohashi I; Jinnai I; Takeuchi H; Bessho M; Hirashima K
    Rinsho Ketsueki; 1998 Mar; 39(3):221-6. PubMed ID: 9577647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute promyelocytic leukemia in a patient with chronic lymphocytic leukemia-A case report.
    Boddu P; Schlette E; Thakral B; Tang G; Pemmaraju N; Kadia T; Ferrajoli A; Ravandi F; Wierda W; Jain N
    Hematol Oncol Stem Cell Ther; 2019 Sep; 12(3):161-165. PubMed ID: 28830803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term survey of outcome in acute promyelocytic leukemia.
    Hu J; Shen Z; Sun H; Wu W; Li X; Sun G; Wang Z
    Chin Med J (Engl); 2000 Feb; 113(2):107-10. PubMed ID: 11775530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case of pediatric acute promyelocytic leukemia presenting as extramedullary tumor of the mandible.
    Yamashita Y; Isomura N; Hamasaki Y; Goto M
    Head Neck; 2013 Oct; 35(10):E310-3. PubMed ID: 22972688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term remission after first-line single-agent treatment with arsenic trioxide of relapsed acute promyelocytic leukemia in an 8-year-old boy.
    Ebinger M; Schwarze CP; Feuchtinger T; Scheel-Walter HG; Lang P; Hildenbrand S; Gessler P; Handgretinger R
    Pediatr Hematol Oncol; 2011 May; 28(4):334-7. PubMed ID: 21345080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyond.
    Tallman MS
    Leukemia; 1998 Sep; 12 Suppl 1():S37-40. PubMed ID: 9777894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incorporation of arsenic trioxide in induction therapy improves survival of patients with newly diagnosed acute promyelocytic leukaemia.
    Song X; Hu X; Lü S; Gao L; Chen L; Yang J; Zhang W; Wang J
    Eur J Haematol; 2014 Jul; 93(1):54-62. PubMed ID: 24592821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
    Quezada G; Kopp L; Estey E; Wells RJ
    Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination therapy with arsenic trioxide, all-trans retinoic acid, and gemtuzumab ozogamicin in recurrent acute promyelocytic leukemia.
    Aribi A; Kantarjian HM; Estey EH; Koller CA; Thomas DA; Kornblau SM; Faderl SH; Laddie NM; Garcia-Manero G; Cortes JE
    Cancer; 2007 Apr; 109(7):1355-9. PubMed ID: 17326049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in the treatment of relapsed acute promyelocytic leukemia.
    Douer D
    Acta Haematol; 2002; 107(1):1-17. PubMed ID: 11818666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial.
    Zhang X; Zhang H; Chen L; Wang M; Xi J; Liu X; Xie M; Li D; Gulati ES; Gong S; Wang H
    Trials; 2018 Sep; 19(1):476. PubMed ID: 30185214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
    Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
    Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study.
    Frankel SR; Eardley A; Heller G; Berman E; Miller WH; Dmitrovsky E; Warrell RP
    Ann Intern Med; 1994 Feb; 120(4):278-86. PubMed ID: 8291820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinoic acid syndrome induced by arsenic trioxide in treating recurrent all-trans retinoic acid resistant acute promyelocytic leukemia.
    Che-Pin Lin ; Huang MJ; Chang IY; Lin WY; Sheu YT
    Leuk Lymphoma; 2000 Jun; 38(1-2):195-8. PubMed ID: 10811463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
    Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
    Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.